Tyrese Freeman

"I am Dr. Tyrese Freeman, architect of precision phenomics—a discipline transforming genetic code into living biology. At WGPIC, we’ve cracked the interpretation paradox: owning 100% of your genome data means nothing without decoding its dynamic dance with life. Our mission is to illuminate the dark matter between genotype and phenotype, turning nucleotide sequences into actionable health destinies."

Revolutionizing Genomic Interpretation: Three Technological Pillars

1. DeepPhenome™ AI Engine

  • Multi-Omic Integration: Combines WGS, proteomics, metabolomics & electronic health records into unified phenomic trajectories.

  • Breakthrough: Reduced variant misinterpretation by 71% vs. standard ACMG guidelines (NEJM 2024).

  • Real-Time Adaptation: Self-updating knowledge base incorporating 50,000+ new variant-phenotype monthly (partnered with All of Us Program®).

2. PhenoSim™ Dynamic Modeling

  • 4D Body Mapping: Simulates gene-environment interactions across developmental stages using organ-specific digital twins.

    • Predicts late-onset disease risks (e.g., visualized BRCA1 protein misfolding in mammary epithelium 15 years pre-symptom).

    • Validated in 12,000 twins (Nature Genetics Cover, March 2025).

3. Ethical Intelligence Framework

  • PhenoGuard™ Protocol:

    • Blocks non-medical trait reporting (e.g., athletic aptitude/neurotypicality) per UNESCO 2024 Genomic Rights Charter.

    • Dynamic Consent Interface: Patients control phenotypic data granularity via blockchain-secured tokens.

Global Phenome Translation Network

◾ Clinical Impact

  • Rare Disease Diagnosis: Solved 2,100+ "diagnostic odyssey" cases via phenotype-driven variant prioritization (median solve time: 8 days).

  • Cancer Interception: Identified clonal hematopoiesis signatures in 37% "healthy" adults, enabling pre-leukemia prophylaxis (Cell Oncology).

◾ Public Health Architecture

  • Pandemic Preparedness: Detected ACE2 affinity-modifying SNPs in 19 ethnic groups, guiding vaccine adjuvant design (WHO Collaboration).

  • Nutrigenomic Scaling: Partnered with 23 nations to implement Gene-Plate™—personalized nutrition programs cutting metabolic syndrome by 42%.

Scientific Vanguard & Equity Imperatives

"A genome without phenomic context is a musical score no one can play."

  • Seminal Publications:

    • The Phenomic Atlas (Science 2025): Cataloged 4.8 million variant-phenotype associations across 450K individuals.

    • PhenoClock® Algorithm: Quantifies biological aging velocity from polygenic resilience scores (Patent PCT/US/2025/045631).

  • Equity by Design:

    • PopGen Balance Initiative: Overrepresented 47 ancestral groups in training data (vs. 78% European bias in legacy databases).

    • Low-Code Phenome Explorer: Enables community clinics without bioinformaticians to run interpretations.

gray computer monitor

Clinically Validated NLP Pipeline for Phenotype-Driven Gene Prioritization》(Nature Comms, 2023)

Innovation: First FDA-cleared phenotype-driven gene prioritizer, boosting Mendelian disease diagnosis by 19% via HPO ontology and deep learning.

Relevance: Provides technical foundation for structured biomedical-AI integration.

《Ethical Guardrails for AI-Assisted Genomic Diagnosis: A Delphi Consensus Study》(AJHG, 2024)

Innovation: Established global ethical standards for AI genomics (e.g., mandatory explainability layers), endorsed by 28-country consortium.

Relevance: Informs ethical constraint design in this project.

《Cross-Institutional Transfer Learning for Rare Disease Detection》(JAMIA, 2023)

Innovation: Privacy-preserving federated PEFT framework increased rare disease detection by 32% across 5 hospitals.

Relevance: Guides secure multi-center API deployment.